In this presentation “Novel Clinical Insights on Inflammation: Resolving not Blocking,” Andrew Heyman, MD, MHSA shares clinical experiences and observations related to health conditions associated with increased inflammatory biomarkers. Dr. Heyman explores the role of specialized pro-resolving mediators (SPMs) in the clinical management of chronic inflammatory conditions, such as chronic pain and fibromyalgia, focusing on evidence from a multi-center case series investigation. Dr. Heyman concludes with insights on novel clinical targets for resolvins in neuroinflammation, in addition to providing a patient algorithm for SPM incorporation within a medical nutrition therapy intervention for inflammatory conditions.
Andrew Heyman, MD, MHSA is an integrative physician and Medical Director of Integrative Medicine at George Washington University.
This presentation took place at the Institute for Functional Medicine (IFM) luncheon sponsored by Metagenics Institute, held in San Diego, CA on May 13, 2016
